Health Care: Drugs

Coronado Biosciences Inc (CNDO: NASDAQ)

$2.2 n/a | n/a%
12/19/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 2.20
52 Week High 3.31
52 Week Low 1.45
Avg. Daily Vol. (Mil) 0.21
Beta (3 year) 1.63
Share Related Items
Mkt Cap (Mil) 97.49
Shares Out (Mil) 44.31
Float (Mil) 30.76
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 20.10
Current Ratio 20.30
LT Debt/ Equity 0.20
Total Debt / Equity 0.20
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 1.41
Price/Cash Flow -3.70
Per Share Data
Earnings -0.73
Sales 0.00
Book Value 1.56
Cash Flow -0.60
Business Summary
Coronado Biosciences Inc is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. Its two main product candidates in clinical development are: TSO and CNDO-109.
General Information
24 New England Executive Par
Suite 105
Burlington, MA 01803
www.coronadobiosciences.com
Industry : Drugs
Sector: Health Care
Employees: 14
CEO: Dr. Lindsay A. Rosenwald
Short Interest
Current Month (Mil) 3.55
Previous Month (Mil) 3.57
Short Interest Ratio (Days) 15.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -30.10
Return on Investments -31.80
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CNDO

Latest CNDO Headlines from TheStreet

More Financial News for CNDO

Press Releases for CNDO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter